Key result
The author argues for the publication of negative findings to potentially save NHS resources, citing the high cost of statin prescribing in general practice as an example.
Answers are grounded in this paper and cite their sources.
An editorial letter questioning the cost-effectiveness of statin prescribing in general practice and advocating for the publication of negative findings.
EDITOR–As Abbasi argues in his Editor's choice, the benefits of publishing negative findings should be obvious.1 As a general practitioner I wonder how many million pounds sterling the NHS could save if the Medical Research Council, the British Heart Foundation, and the Lancet shared this view. An example is in the prescribing of statins. They are a major cost in my practice, as I am sure they are to many practitioners. Even in general practice I recognised …
No takes yet. Share an insight, caveat, or question.
A J Jenkins (2003) reported a letter. Statins was evaluated. The author argues for the publication of negative findings to potentially save NHS resources, citing the high cost of statin prescribing in general practice as an example.
Synapse has enriched 10 related papers. Consider them for comparative context: